Showing results (181-190 of 865) with videos related to
Sort By:
Pageof 87
Vascular Medicine (London, England)|May 12, 1998
The occurrence of Raynaud's phenomenon in a general population: the Framingham StudyF N Brand, M G Larson, W B Kannel, et al.Clinical Therapeutics|January 1, 1992
Efficacy and tolerability of lovastatin in elderly hypercholesterolemic patientsR B D'Agostino, W B Kannel, M N Stepanians, et al.The American Journal of Cardiology|January 1, 1992
A comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemiaR B D'Agostino, W B Kannel, M N Stepanians, et al.International Journal of Epidemiology|January 1, 1989
Trends in CHD and risk factors at age 55-64 in the Framingham StudyR B D'Agostino, W B Kannel, A J Belanger, et al.Journal of Clinical Epidemiology|January 1, 1988
Gout and coronary heart disease: the Framingham StudyR D Abbott, F N Brand, W B Kannel, et al.The New England Journal of Medicine|April 29, 1982
Epidemiologic features of chronic atrial fibrillation: the Framingham studyW B Kannel, R D Abbott, D D Savage, et al.American Journal of Epidemiology|May 1, 1978
The relationship of psychosocial factors to coronary heart disease in the Framingham study. I. Methods and risk factorsS G Haynes, S Levine, N Scotch, et al.American Heart Journal|November 1, 1994
Does exercise reduce mortality rates in the elderly? Experience from the Framingham Heart StudyS E Sherman, R B D'Agostino, J L Cobb, et al.American Heart Journal|March 1, 1994
Hematocrit and the risk of cardiovascular disease--the Framingham study: a 34-year follow-upD R Gagnon, T J Zhang, F N Brand, et al.JAMA|September 4, 1987
Fibrinogen and risk of cardiovascular disease. The Framingham StudyW B Kannel, P A Wolf, W P Castelli, et al.Pageof 87